Hasan Haci Yeter, Murat Altunok, Erdem Cankaya, Saliha Yildirim, Serkan Akturk, Serkan Bakirdogen, Hadim Akoğlu, Mesudiye Bulut, Tuncay Sahutoglu, Arda Erdut, Mehmet Ozkahya, Yener Koc, Onur Tunca, Ekrem Kara, Müge Erek, Mehmet Polat, Tulin Akagun, Galip Guz
PURPOSE: Incremental peritoneal dialysis (IPD) could decrease unfavorable glucose exposure results and preserve (RKF). However, there is no standardization of dialysis prescriptions for patients undergoing IPD. We designed a prospective observational multi-center study with a standardized IPD prescription to evaluate the effect of IPD on RKF, metabolic alterations, blood pressure control, and adverse outcomes. METHODS: All patients used low GDP product (GDP) neutral pH solutions in both the incremental continuous ambulatory peritoneal dialysis (ICAPD) group and the retrospective standard PD (sPD) group...
May 14, 2024: International Urology and Nephrology